| Year |
Citation |
Score |
| 2010 |
Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarskog LF. Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophrenia Research. 118: 292-9. PMID 20067857 DOI: 10.1016/J.Schres.2009.12.027 |
0.536 |
|
| 2007 |
Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood Neuroscience. 149: 582-591. PMID 17916412 DOI: 10.1016/J.Neuroscience.2007.06.036 |
0.358 |
|
| 2007 |
Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 95-102. PMID 16641945 DOI: 10.1038/Sj.Npp.1301074 |
0.427 |
|
| 2006 |
Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research. 81: 47-63. PMID 16226876 DOI: 10.1016/J.Schres.2005.08.014 |
0.548 |
|
| 2005 |
Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29: 846-858. PMID 15908096 DOI: 10.1016/J.Pnpbp.2005.03.010 |
0.546 |
|
| 2003 |
Lewis DA, Glantz LA, Pierri JN, Sweet RA. Altered Cortical Glutamate Neurotransmission in Schizophrenia: Evidence from Morphological Studies of Pyramidal Neurons Annals of the New York Academy of Sciences. 1003: 102-112. PMID 14684438 DOI: 10.1196/Annals.1300.007 |
0.653 |
|
| 2003 |
Glantz L, Gilmore J, Lieberman J, Jarskog L. Decreased PAR-4 in the temporal cortex of subjects with schizophrenia Schizophrenia Research. 60: 62. DOI: 10.1016/S0920-9964(03)80569-8 |
0.664 |
|
| 2001 |
Glantz LA, Lewis DA. Dendritic spine density in schizophrenia and depression. Archives of General Psychiatry. 58: 203. PMID 11177126 DOI: 10.1001/Archpsyc.58.2.203 |
0.551 |
|
| 2000 |
Glantz LA, Austin MC, Lewis DA. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry. 48: 389-97. PMID 10978722 DOI: 10.1016/S0006-3223(00)00923-9 |
0.665 |
|
| 2000 |
Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry. 57: 65-73. PMID 10632234 DOI: 10.1001/Archpsyc.57.1.65 |
0.686 |
|
| 1998 |
Gullion K, Glantz L, Lewis D. 384. Are PFC pyramidal neurons in the thalamic recipient zone altered in schizophrenia? Biological Psychiatry. 43: S115-S116. DOI: 10.1016/S0006-3223(98)90832-0 |
0.608 |
|
| 1997 |
Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of General Psychiatry. 54: 943-52. PMID 9337775 DOI: 10.1001/Archpsyc.1997.01830220065010 |
0.687 |
|
| 1997 |
Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of General Psychiatry. 54: 660-9. PMID 9236550 DOI: 10.1001/archpsyc.1997.01830190088009 |
0.707 |
|
| 1997 |
Lewis DA, Glantz LA. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia Schizophrenia Research. 24: 39. DOI: 10.1016/S0920-9964(97)82110-X |
0.577 |
|
| 1995 |
Lewis D, Glantz L. Selective decrease of synaptophysin immunoreactivity in the prefrontal cortex of schizophrenic subjects Schizophrenia Research. 15: 64. DOI: 10.1016/0920-9964(95)95202-K |
0.511 |
|
| 1994 |
Glantz L, Lewis D. Decreased synaptophysin immunoreactivity in prefrontal cortex of schizophrenics Biological Psychiatry. 35: 717. DOI: 10.1016/0006-3223(94)91024-3 |
0.525 |
|
| Show low-probability matches. |